10mm与14mm金属支架治疗不可切除胰腺癌所致远端胆道梗阻的多中心随机对照试验
这项多中心随机对照试验纳入118例不可切除胰腺癌需胆道引流的患者,比较10mm与14mm无覆膜金属支架。
要点
- 两组早期和晚期不良事件发生率均无显著差异。
- 14mm支架并未显著延长至复发胆道梗阻时间或总生存。
核心结论
- 14mm组显示出更长的至复发胆道梗阻时间,但差异未达到统计学显著性。
- 两组不良事件无显著差异。
研究设计与样本
- 多中心随机对照试验,纳入不可切除胰腺癌需胆道引流的患者,1:1随机分配至10mm或14mm无覆膜金属支架组,经主十二指肠乳头置入。
- 共纳入118例患者,来自20家机构,10mm组60例,14mm组58例。
- 主要终点为至复发胆道梗阻时间(TRBO),次要终点为不良事件(AEs)和总生存(OS)。
临床怎么用
- 在不可切除胰腺癌所致远端胆道梗阻的胆道引流中,14mm与10mm无覆膜金属支架在不良事件方面无显著差异。
- 14mm支架在复发胆道梗阻和支架通畅性方面未见统计学显著优势,临床选择需综合评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: ERCP with metal stent (MS) placement is the standard treatment for biliary drainage in patients with unresectable pancreatic cancer. A 10-mm diameter MS is generally used; however, a larger stent may provide longer patency. This study aimed to compare the outcomes of an uncovered 14-mm MS with those of an uncovered 10-mm MS. METHODS: This multicenter randomized controlled trial enrolled patients with unresectable pancreatic cancer who required biliary drainage. After 1:1 randomization, either an uncovered 10-mm or 14-mm MS was placed through the major duodenal papilla, and the outcomes were compared. The primary end point was time to recurrent biliary obstruction (TRBO), and the secondary end points were adverse events (AEs) and overall survival (OS). RESULTS: A total of 118 patients were enrolled from 20 institutions (60 in the 10-mm group and 58 in the 14-mm group). Recurrent biliary obstruction occurred in 41.7% versus 25.8% of patients (P = .08). The median TRBO was 10.6 months versus not reached (P = .10), and the median OS was 7.5 months versus 8.7 months (P = .95) in the 10- and 14-mm groups, respectively. Early AEs occurred in 6.7% and 8.6% of patients (P = .74). No significant difference in late AEs was observed between the groups (21.7% vs 17.2%, P = .64). CONCLUSIONS: The 14-mm group demonstrated a longer TRBO; however, the difference did not reach statistical significance. No significant differences in AEs were observed between the groups. CLINICAL TRIAL REGISTRATION: The University Hospital Medical Information Network Center (registration no. UMIN000035387).
引用
- Ishiwatari H, Nakahara K, Kawaguchi S, et al. A multicenter randomized controlled trial comparing 10-mm versus 14-mm metallic stents for distal biliary obstruction caused by unresectable pancreatic carcinoma. Gastrointest Endosc. 2026. PMID: 42349763. doi:10.1016/j.gie.2026.06.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。